Clinical Trial Update: Clinical Pre-screening Protocol for Ovarian Cancer

View source ↗

Summary

Allarity Therapeutics reports an ongoing clinical trial evaluating a pre-screening protocol for ovarian cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Allarity Therapeutics | Conditions: Ovarian Cancer | Status: RECRUITING